CompareMarketResearchRequest a sample
Home / Healthcare / Lateral Flow Assay

Healthcare · Market report

Lateral Flow Assay Market Size, Share and Forecast 2026-2036

The global lateral flow assay market is worth USD 10.0 bn in 2026 and is forecast to reach USD 16.3 bn by 2036, growing at a 5.0% CAGR. United States is the largest country market and Infectious disease is the largest by application segment.

USD 10.0 bnMarket size 2026
USD 16.3 bnForecast 2036
5.0%CAGR 2026-2036
United StatesLargest country

Request a free sample Jump to the forecast

Report price: Starts from USD 1,999

5 segmentation views25 countries2026 to 2036 yearly forecast

Market overview

The global lateral flow assay market is worth USD 10.0 bn in 2026 and is forecast to reach USD 16.3 bn by 2036, growing at a 5.0% CAGR. United States is the largest country market and Infectious disease is the largest by application segment.

ScopeRapid immunochromatographic test strips and cassettes read by eye or reader: infectious disease, pregnancy and fertility, drugs of abuse, cardiac markers and food safety.
IndustryHealthcare
Value 2025USD 9.5 bn
Value 2026USD 10.0 bn
Value 2036USD 16.3 bn
CAGR 2026-20365.0%
Volume 20264,431 million tests
Volume 20367,218 million tests
Average price 2026USD 2.26 per test
Report priceStarts from USD 1,999
PublishedNovember 2026

Request a free sample of this report

Lateral Flow Assay market size and forecast, 2026-2036

Exhibit 1The global lateral flow assay market is forecast to grow from USD 10.0 bn in 2026 to USD 16.3 bn by 2036, a rise of 63%Global market value in USD: 2025 base year, 2026 estimate and forecast to 2036. CAGR 2026 to 2036: 5.0%
Lateral Flow Assay market value, 2025 to 2036Market value by year. 2025: USD 9.5 bn; 2026: USD 10.0 bn; 2027: USD 10.5 bn; 2028: USD 11.0 bn; 2029: USD 11.6 bn; 2030: USD 12.2 bn; 2031: USD 12.8 bn; 2032: USD 13.4 bn; 2033: USD 14.1 bn; 2034: USD 14.8 bn; 2035: USD 15.5 bn; 2036: USD 16.3 bn. Compound annual growth rate 2026 to 2036: 5.0%.202510.0 bn202612.8 bn203116.3 bn20365.0% CAGR

Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.

YearMarket value
2026USD 10.0 bn
2027USD 10.5 bn
2028USD 11.0 bn
2029USD 11.6 bn
2030USD 12.2 bn
2031USD 12.8 bn
2032USD 13.4 bn
2033USD 14.1 bn
2034USD 14.8 bn
2035USD 15.5 bn
2036USD 16.3 bn

Lateral Flow Assay market segmentation

By application

Exhibit 2Infectious disease is the largest segment by application, with 44.0% of 2026 revenueEstimated share of 2026 global revenue, by application
Lateral Flow Assay market share by application, 2026Share of 2026 revenue by application. Infectious disease: 44.0%; Pregnancy and fertility: 18.0%; Drugs of abuse: 12.0%; Cardiac markers: 10.0%; Food safety and veterinary: 10.0%; Others: 6.0%.Infectious disease44.0%Pregnancy and fertility18.0%Drugs of abuse12.0%Cardiac markers10.0%Food safety and veterinary10.0%Others6.0%

Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.

SegmentShare 2026Share 2036Value 2026CAGR 2026-36
Infectious disease44.0%42.8%USD 4.4 bn4.7%
Pregnancy and fertility18.0%16.7%USD 1.8 bn4.2%
Cardiac markers10.0%11.2%USD 1.0 bn6.2%
Drugs of abuse12.0%11.7%USD 1.2 bn4.7%
Food safety and veterinary10.0%11.8%USD 1.0 bn6.7%
Others6.0%5.8%USD 601 mn4.7%

By end user

Exhibit 3Home testing adds the most revenue by end user, growing from USD 3.6 bn in 2026 to USD 6.0 bn by 2036Estimated revenue in USD by end user, 2026 and 2036 forecast
Lateral Flow Assay market by end user, 2026 and 2036Revenue by end user in 2026 and 2036. Home testing: USD 3.6 bn in 2026, USD 6.0 bn in 2036, change +65%; Hospitals and clinics: USD 3.4 bn in 2026, USD 5.4 bn in 2036, change +58%; Laboratories: USD 1.4 bn in 2026, USD 2.2 bn in 2036, change +58%; Food and veterinary: USD 1.0 bn in 2026, USD 1.9 bn in 2036, change +90%; Others: USD 601 mn in 2026, USD 862 mn in 2036, change +43%.20262036 forecastChangeHome testing+65%3.6 bn6.0 bnHospitals and clinics+58%3.4 bn5.4 bnLaboratories+58%1.4 bn2.2 bnFood and veterinary+90%1.0 bn1.9 bnOthers+43%601 mn862 mn

Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.

SegmentShare 2026Share 2036Value 2026CAGR 2026-36
Hospitals and clinics34.0%32.9%USD 3.4 bn4.7%
Home testing36.0%36.6%USD 3.6 bn5.2%
Laboratories14.0%13.6%USD 1.4 bn4.7%
Food and veterinary10.0%11.7%USD 1.0 bn6.7%
Others6.0%5.3%USD 601 mn3.7%

By assay format

SegmentShare 2026Share 2036Value 2026CAGR 2026-36
Sandwich assays48.0%46.0%USD 4.8 bn4.5%
Competitive assays24.0%22.0%USD 2.4 bn4.1%
Multiplex assays14.0%18.0%USD 1.4 bn7.7%
Dipstick assays14.0%14.0%USD 1.4 bn5.0%

By product

SegmentShare 2026Share 2036Value 2026CAGR 2026-36
Kits and reagents55.0%50.0%USD 5.5 bn4.0%
Readers and analyzers25.0%28.0%USD 2.5 bn6.2%
Consumables and strips20.0%22.0%USD 2.0 bn6.0%

By labelling technology

SegmentShare 2026Share 2036Value 2026CAGR 2026-36
Colloidal gold52.0%46.0%USD 5.2 bn3.7%
Fluorescence20.0%24.0%USD 2.0 bn6.9%
Latex bead12.0%11.0%USD 1.2 bn4.1%
Quantum dot and nanoparticle16.0%19.0%USD 1.6 bn6.8%

Top 25 countries for lateral flow assay by revenue

Countries are ranked by revenue earned from sales in the country, not by where the product is made. The ten largest hold 76.0% of 2026 revenue and the 25 countries below together hold 93.8%.

Exhibit 4United States is the largest country market at USD 2.8 bn in 2026, and the three largest countries hold 48.0% of global revenueEstimated 2026 revenue in USD and share of the global market, ten largest countries
Lateral Flow Assay market, ten largest countries in 2026Ten largest countries by 2026 revenue. United States: USD 2.8 bn, 28.0%; China: USD 1.4 bn, 14.0%; Germany: USD 601 mn, 6.0%; India: USD 601 mn, 6.0%; Japan: USD 501 mn, 5.0%; United Kingdom: USD 401 mn, 4.0%; France: USD 401 mn, 4.0%; Brazil: USD 351 mn, 3.5%; Italy: USD 301 mn, 3.0%; South Korea: USD 251 mn, 2.5%.United States2.8 bn 28.0%China1.4 bn 14.0%Germany601 mn 6.0%India601 mn 6.0%Japan501 mn 5.0%United Kingdom401 mn 4.0%France401 mn 4.0%Brazil351 mn 3.5%Italy301 mn 3.0%South Korea251 mn 2.5%

Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.

#CountryValue 2026Share 2026Value 2036CAGR 2026-36
1United StatesUSD 2.8 bn28.0%USD 4.3 bn4.4%
2ChinaUSD 1.4 bn14.0%USD 2.4 bn5.4%
3GermanyUSD 601 mn6.0%USD 882 mn3.9%
4IndiaUSD 601 mn6.0%USD 1.4 bn9.0%
5JapanUSD 501 mn5.0%USD 735 mn3.9%
6United KingdomUSD 401 mn4.0%USD 588 mn3.9%
7FranceUSD 401 mn4.0%USD 588 mn3.9%
8BrazilUSD 351 mn3.5%USD 653 mn6.4%
9ItalyUSD 301 mn3.0%USD 441 mn3.9%
10South KoreaUSD 251 mn2.5%USD 424 mn5.4%
11SpainUSD 243 mn2.4%USD 380 mn4.6%
12CanadaUSD 209 mn2.1%USD 322 mn4.4%
13MexicoUSD 184 mn1.8%USD 282 mn4.3%
14NetherlandsUSD 162 mn1.6%USD 250 mn4.4%
15AustraliaUSD 154 mn1.5%USD 237 mn4.4%
16IndonesiaUSD 141 mn1.4%USD 281 mn7.1%
17NigeriaUSD 124 mn1.2%USD 247 mn7.1%
18South AfricaUSD 109 mn1.1%USD 168 mn4.4%
19TurkeyUSD 96 mn1.0%USD 147 mn4.3%
20RussiaUSD 84 mn0.8%USD 129 mn4.4%
21ThailandUSD 69 mn0.7%USD 106 mn4.4%
22PakistanUSD 63 mn0.6%USD 126 mn7.1%
23VietnamUSD 53 mn0.5%USD 106 mn7.2%
24PolandUSD 45 mn0.5%USD 70 mn4.5%
25SwedenUSD 40 mn0.4%USD 60 mn4.2%
Rest of worldUSD 626 mn6.2%USD 975 mn4.5%
Exhibit 5United States and China account for 40% of the USD 6.3 bn the market is forecast to add by 2036Forecast revenue added between 2026 and 2036 by country, in USD
Lateral Flow Assay market, where the growth to 2036 comes fromRevenue added between 2026 and 2036. Market value 2026: USD 10.0 bn. United States: +USD 1.5 bn; China: +USD 980 mn; India: +USD 819 mn; Brazil: +USD 302 mn; Germany: +USD 280 mn; 20 other countries: +USD 2.1 bn; Rest of world: +USD 348 mn. Market value 2036: USD 16.3 bn.Market value 202610.0 bnUnited States+1.5 bnChina+980 mnIndia+819 mnBrazil+302 mnGermany+280 mn20 other countries+2.1 bnRest of world+348 mnMarket value 203616.3 bn

Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.

Competitive landscape

Group 1: Global leaders

  • Abbott
  • Roche
  • QuidelOrtho
  • Siemens Healthineers
  • ACON Laboratories
  • Wondfo

Group 2: Regional and specialist players

  • SD Biosensor
  • OraSure Technologies
  • Bio-Rad Laboratories
  • Becton Dickinson
  • Princeton BioMeditech
  • Boditech Med
  • Getein Biotech

Group 3: Emerging and niche players

  • Biosynex
  • Lumos Diagnostics
  • Abingdon Health
  • Global Access Diagnostics
  • Nano-Ditech

Research methodology

Every figure on this page comes from the research framework that we apply to all of the markets we cover. The 2025 base for the lateral flow assay market is built from the volume sold and the price that buyers pay, and is cross-checked against the size of the wider industry the market belongs to. Where a market can be sized in more than one way, the routes are compared before a figure is set.

The forecast runs year by year from the 2025 base to 2036. Growth in each year reflects demand from the industries that buy the product, adoption of new technology, pricing, regulation and replacement cycles. Volume and price are modelled together, so revenue in each year equals volume multiplied by average price. The 2026 to 2036 compound annual growth rate of 5.0% is calculated from the resulting values.

The market is divided by application, by end user, by assay format, by product, by labelling technology. The 25 largest countries are ranked by revenue earned from sales to buyers in each country, not by where the product is made. Segment values and country values add up to the market total in every year, and every report is checked for consistency before it is published.

Companies are placed in three groups: global leaders, regional and specialist players, and emerging and niche players. The groups describe how companies compete in the market. They are not a ranking and they are not market shares.

Our analysts also carry out primary research. Customized reports add interviews with key opinion leaders, such as senior executives, technical specialists and buyers, to test the assumptions behind the numbers for the question being asked.

Read the full research methodology

Frequently asked questions

How big is the lateral flow assay market?

The global lateral flow assay market is estimated at USD 9.5 bn in 2025 and USD 10.0 bn in 2026.

How fast will the lateral flow assay market grow?

It is forecast to reach USD 16.3 bn by 2036, a compound annual growth rate of 5.0% from 2026, an increase of USD 6.3 bn.

Which country is the largest market for lateral flow assay?

United States is the largest market by revenue at USD 2.8 bn in 2026, 28.0% of the global total. The three largest countries together hold 48.0%.

Which country is growing fastest?

Among the ten largest markets, India is growing fastest at 9.0% a year from 2026 to 2036.

Which lateral flow assay segment is largest?

In the by application split, Infectious disease is the largest segment with 44.0% of 2026 revenue.

Who are the leading lateral flow assay companies?

Global leaders include Abbott, Roche, QuidelOrtho, Siemens Healthineers.

Need the full report?

Request a sample to see the structure, tables and country detail.

Request a free sample

Related markets in Healthcare

← Laminar Air Flow Liposome →

All Healthcare markets →

Request a sample